Company Filing History:
Years Active: 2007-2010
Title: The Innovative Contributions of Bengt Anders Brunmark
Introduction
Bengt Anders Brunmark is a notable inventor based in La Jolla, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cell proliferative disorders. With a total of 2 patents to his name, Brunmark's work is recognized for its potential impact on medical treatments.
Latest Patents
Brunmark's latest patents focus on N-substituted tricyclic 3-aminopyrazole derivatives. These compounds serve as inhibitors for the platelet-derived growth factor receptor (PDGF-R) kinase. The inventions are directed towards pharmaceutical compositions that can be utilized in treating conditions such as tumors and other cell proliferative disorders. The methods for preparing these derivatives are also outlined in his patents, showcasing his innovative approach to addressing critical health issues.
Career Highlights
Brunmark is currently associated with Janssen Pharmaceutica NV, a company known for its commitment to developing innovative pharmaceutical solutions. His work at Janssen has allowed him to further his research and contribute to advancements in medical science.
Collaborations
Throughout his career, Brunmark has collaborated with esteemed colleagues, including Chih Yung Ho and Stuart Emanuel. These partnerships have likely enhanced the scope and impact of his research efforts.
Conclusion
Bengt Anders Brunmark's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment of cell proliferative disorders.